Medifast, Inc. (LON:0K05)
10.62
-0.10 (-0.95%)
At close: Nov 21, 2025
Medifast Revenue
Medifast had revenue of $89.41M USD in the quarter ending September 30, 2025, a decrease of -36.21%. This brings the company's revenue in the last twelve months to $429.70M, down -36.29% year-over-year. In the year 2024, Medifast had annual revenue of $602.46M, down -43.80%.
Revenue (ttm)
$429.70M
Revenue Growth
-36.29%
P/S Ratio
0.26
Revenue / Employee
$852.57K
Employees
504
Market Cap
83.08M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 602.46M | -469.59M | -43.80% |
| Dec 31, 2023 | 1.07B | -526.52M | -32.94% |
| Dec 31, 2022 | 1.60B | 72.49M | 4.75% |
| Dec 31, 2021 | 1.53B | 591.25M | 63.25% |
| Dec 31, 2020 | 934.84M | 221.17M | 30.99% |
| Dec 31, 2019 | 713.67M | 212.67M | 42.45% |
| Dec 31, 2018 | 501.00M | 199.44M | 66.14% |
| Dec 31, 2017 | 301.56M | 27.03M | 9.85% |
| Dec 31, 2016 | 274.53M | 1.76M | 0.65% |
| Dec 31, 2015 | 272.77M | -12.51M | -4.39% |
| Dec 31, 2014 | 285.29M | -38.77M | -11.96% |
| Dec 31, 2013 | 324.05M | 5.48M | 1.72% |
| Dec 31, 2012 | 318.57M | 20.38M | 6.84% |
| Dec 31, 2011 | 298.19M | 40.64M | 15.78% |
| Dec 31, 2010 | 257.55M | 87.81M | 51.73% |
| Dec 31, 2009 | 169.74M | 59.67M | 54.21% |
| Dec 31, 2008 | 110.08M | 26.30M | 31.39% |
| Dec 31, 2007 | 83.78M | 9.69M | 13.08% |
| Dec 31, 2006 | 74.09M | 33.96M | 84.62% |
| Dec 31, 2005 | 40.13M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Compass Group | 33.92B |
| Marks and Spencer Group | 15.28B |
| Kingfisher | 12.84B |
| NEXT plc | 6.40B |
| Barratt Redrow | 5.58B |
| Entain | 5.16B |
| InterContinental Hotels Group | 3.74B |
| Persimmon | 3.39B |
Medifast News
- 11 days ago - Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference - Business Wire
- 20 days ago - Medifast's Q3 Loss Wider Than Expected, Sales Decline 36% Y/Y - Nasdaq
- 21 days ago - Medifast Inc (MED) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - GuruFocus
- 21 days ago - Q3 2025 Medifast Inc Earnings Call Transcript - GuruFocus
- 21 days ago - Medifast outlines Q4 2025 revenue guidance of $65M–$80M amid strategic shift to metabolic health solutions - Seeking Alpha
- 21 days ago - Medifast, Inc. (MED) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Medifast, Inc. 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 21 days ago - Medifast Inc Q3 2025 Earnings: EPS of -$0.21 Beats Estimate, Revenue of $89. ... - GuruFocus